BeyondSpring Inc (NASDAQ:BYSI) — Market Cap & Net Worth
Market Cap & Net Worth: BeyondSpring Inc (BYSI)
BeyondSpring Inc (NASDAQ:BYSI) has a market capitalization of $29.15 Million ($29.15 Million) as of September 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #23970 globally and #5178 in its home market, demonstrating a 12.74% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying BeyondSpring Inc's stock price $0.71 by its total outstanding shares 41119820 (41.12 Million). Also see total assets of BeyondSpring Inc for a full breakdown of the balance sheet.
BeyondSpring Inc Market Cap History: 2017 to 2026
BeyondSpring Inc's market capitalization history from 2017 to 2026. Data shows change from $1.20 Billion to $29.15 Million (-28.26% CAGR). Also see BeyondSpring Inc (BYSI) cash conversion ratio for how efficiently the company converts equity into cash flow.
Index Memberships
BeyondSpring Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.67 Trillion | 0.00% | #681 of 976 |
|
NASDAQ Composite
IXIC
|
$41.95 Trillion | 0.00% | #2246 of 3165 |
Weight: BeyondSpring Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
BeyondSpring Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how BeyondSpring Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check BYSI share price today for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
21.14x
BeyondSpring Inc's market cap is 21.14 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2020 | $501.66 Million | $180.00K | -$60.97 Million | 2787.01x | N/A |
| 2021 | $186.27 Million | $1.35 Million | -$64.18 Million | 137.88x | N/A |
| 2022 | $77.31 Million | $1.35 Million | -$33.28 Million | 57.22x | N/A |
| 2023 | $37.01 Million | $1.75 Million | -$21.03 Million | 21.14x | N/A |
Competitor Companies of BYSI by Market Capitalization
Companies near BeyondSpring Inc in the global market cap rankings as of September 18, 2026. Review BeyondSpring Inc tangible book value ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to BeyondSpring Inc by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #185 globally with a market cap of $130.87 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #337 globally with a market cap of $79.84 Billion USD.
- CSL Ltd (AU:CSL): Ranked #455 globally with a market cap of $60.95 Billion USD ( AU$86.14 Billion AUD).
- Moderna Inc (NASDAQ:MRNA): Ranked #504 globally with a market cap of $54.14 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #185 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $130.87 Billion | $516.34 |
| #337 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $79.84 Billion | $789.45 |
| #455 | CSL Ltd | AU:CSL | $60.95 Billion | AU$177.56 |
| #504 | Moderna Inc | NASDAQ:MRNA | $54.14 Billion | $158.07 |
BeyondSpring Inc Historical Marketcap From 2017 to 2026
Between 2017 and today, BeyondSpring Inc's market cap moved from $1.20 Billion to $ 29.15 Million, with a yearly change of -28.26%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $29.15 Million | -56.52% |
| 2025 | $67.03 Million | 0.00% |
| 2024 | $67.03 Million | +81.11% |
| 2023 | $37.01 Million | -52.13% |
| 2022 | $77.31 Million | -58.50% |
| 2021 | $186.27 Million | -62.87% |
| 2020 | $501.66 Million | -21.29% |
| 2019 | $637.36 Million | -17.33% |
| 2018 | $771.00 Million | -35.52% |
| 2017 | $1.20 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 18th, 2026 the market cap of BeyondSpring Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $29.15 Million USD |
| MoneyControl | $29.15 Million USD |
| MarketWatch | $29.15 Million USD |
| marketcap.company | $29.15 Million USD |
| Reuters | $29.15 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About BeyondSpring Inc
BeyondSpring Inc., a clinical stage biopharmaceutical company, focuses on developing and selling clinical-stage biopharmaceutical therapies focused on oncology and immunology. The company operates through two segments: the Plinabulin pipeline and the TPD platform. The company's lead asset is Plinabulin, a selective immunomodulating microtubule-binding agent that has completed Phase III clinical t… Read more